Stock UniverseDerived research view · source repositories remain read-only

Axogen, Inc. (AXGN)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Qualified
Selection Score
35.01
Global Rank
1259
Market Cap
1.65B
Latest Close
42.80
RS Composite
23.33% · G#390

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-1.56%
3M
49.91%
6M
51.08%
1Y
292.66%
3Y
403.53%
5Y
110.84%
10Y
669.78%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 800.11K · 30-day average: 945.81K · Max drawdown over stored range: -93.54%

Research Snapshot

Relative Strength vs SPX

RS Composite23.33%
20D RS-2.04%
60D RS23.58%
120D RS35.77%
Global RS Rank390 · 88.38% percentile
Qualified+ RS Rank157 · 87.52% percentile
Group ScopeQualified+
Primary RS Rank12 · 91.55% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank83 / 246
Primary Percentile66.67
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-28238.10M178.61M-9.02M-31.45M-0.64-3.07M7.51M-10.58M49M75.01%-3.79%-13.21%-1.29%-4.45%101.60M48.39M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-0.64-66.4x$4.888.8x$-0.22-197.3x$-0.06-679.7x

Shares Diluted: 49M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue112.3127.358138.584159.012187.338225.208
Revenue Growth (YoY)5.237%13.409%8.815%14.741%17.814%20.215%
Gross Profit90.719104.427108.809121.869141.977167.353
Operating Income-23.182-25.416-29.707-21.462-3.287-7.849
Free Cash Flow-31.531-41.216-36.144-19.5881.434-2.933
Free Cash Flow Per Share-0.789-1-0.859-0.4570.032-0.064
EPS (Diluted) GAAP-0.599999-0.654739-0.687876-0.506453-0.225135-0.340996
EPS Growth
EPS Non-GAAP
Gross Margin80.783%81.995%78.515%76.641%75.787%74.31%
Operating Margin-20.643%-19.956%-21.436%-13.497%-1.755%-3.485%
Profit Margin-21.181%-21.188%-20.888%-13.657%-5.319%-6.973%
Free Cash Flow Margin-28.077%-32.362%-26.081%-12.319%0.765%-1.302%
Shares Outstanding (Diluted)39.966941.214942.083142.878544.257846.0503
Shares Change (YoY)1.866%3.122%2.107%1.89%3.217%4.05%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-2861.46M75.16%-2.83M-4.61%-19.58M-31.87%-0.3851.59M101.60M48.39Mprocessed
2025 Q42026-02-2459.90M74.13%-9.77M-16.31%-13.16M-21.96%-0.2846.49M41.53M48.39Mprocessed
2025 Q32025-10-2960.08M76.55%1.91M3.18%708.00K1.18%0.0149.09M35.79M48.16Mprocessed
2025 Q22025-08-0556.66M74.16%1.67M2.95%579.00K1.02%0.0147.98M29.92M47.94Mprocessed
2025 Q12025-05-0848.56M71.94%-1.66M-3.42%-3.83M-7.90%-0.0845.20M22.07M47.72Mprocessed
2024 Q42025-02-2649.41M76.06%2.02M4.08%450.00K0.91%0.0146.20M33.48M47.50Mprocessed
2024 Q32024-11-0748.64M74.91%-316.00K-0.65%-1.86M-3.82%-0.0443.88M24.53M47.27Mprocessed
2024 Q22024-08-0847.91M73.77%-428.00K-0.89%-1.92M-4.01%-0.0443.71M21.13M47.05Mprocessed
2024 Q12024-05-0241.38M78.83%-4.56M-11.02%-6.63M-16.04%-0.1543.23M17.63M46.83Mprocessed
2023 Q42024-03-0542.92M78.66%-3.19M-7.44%-3.89M-9.07%-0.0943.05M64.53M46.60Mprocessed
2023 Q32023-11-0741.27M80.51%-4.03M-9.75%-4.09M-9.91%-0.1043.02M32.59M46.38Mprocessed
2023 Q22023-08-0838.16M81.06%-6.90M-18.09%-6.66M-17.46%-0.1642.86M34.53M46.15Mprocessed
2023 Q12023-05-0936.66M81.70%-7.34M-20.02%-7.07M-19.29%-0.1742.57M37.87M45.93Mprocessed
2022 Q42023-03-1436.16M83.02%-5.61M-15.51%-5.42M-14.97%-0.1342.31M48.79M45.71Mprocessed
2022 Q32022-11-0836.96M83.29%-4.86M-13.14%-4.32M-11.68%-0.1042.22M53.11M45.49Mprocessed
2022 Q22022-08-0534.45M81.76%-7.92M-23.00%-7.74M-22.46%-0.1841.99M58.03M45.26Mprocessed
2022 Q12022-05-0531.01M82.11%-11.32M-36.51%-11.47M-37.01%-0.2741.80M67.42M45.04Mprocessed
2021 Q42022-02-2531.54M82.79%-5.35M-16.97%-5.29M-16.76%-0.1341.60M84.09M44.82Mprocessed
2021 Q32021-11-0431.20M83.21%-6.69M-21.44%-7.14M-22.88%-0.1741.47M91.72M46.24Mprocessed
2021 Q22021-08-0533.58M78.88%-7.15M-21.30%-7.90M-23.52%-0.1941.08M99.92M46.08Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.